Associations of early life stress with leptin and ghrelin in healthy young adults.
Adversity
Childhood Maltreatment
Ghrelin
Leptin
Parental Loss
Trauma
Journal
Psychoneuroendocrinology
ISSN: 1873-3360
Titre abrégé: Psychoneuroendocrinology
Pays: England
ID NLM: 7612148
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
08
09
2022
revised:
13
12
2022
accepted:
13
12
2022
pmc-release:
01
03
2024
pubmed:
29
12
2022
medline:
18
2
2023
entrez:
28
12
2022
Statut:
ppublish
Résumé
Childhood adversity is a major risk factor for cardiometabolic health problems. Stress-related changes in diet suggest a role for endocrine factors that influence dietary intake, such as leptin and ghrelin. These hormones influence metabolism and may contribute to the relationship of early adversity, mental, and cardiometabolic health. This study examined levels of leptin and ghrelin in a sample of young adults with and without early life stress (ELS). Young adults ages 18-40 (N = 200; 68.5% female) were recruited from the community. Participants with ELS (N = 118) had childhood maltreatment, and a subset, n = 92 (78.0%) also had parental loss, and n = 65 (55.1%) also had a current psychiatric disorder. Control participants (N = 82) had no maltreatment, parental loss, or psychiatric disorders. Standardized interviews and self-reports assessed demographics, adversity, medical/psychiatric history, and health behaviors. Exclusion criteria included medical conditions and current medications other than hormonal contraceptives. Body Mass Index (BMI) and other anthropometrics were measured, and fasting plasma was assayed for total ghrelin and leptin with the Bio-Plex Pro Human Diabetes Panel. While ELS was significantly associated with greater leptin (r = .16, p = .025), a finding which held when adjusted for age and sex (F(3196)= 28.32, p = .011), this relationship was abolished when accounting for BMI (p = .44). Participants with ELS also had significantly lower total ghrelin (r = .21, p = .004), which held adjusting for age and sex (p = .002) and was attenuated (p = .045) when the model included BMI (F=46.82, p < .001). Current psychiatric disorder was also a significant predictor of greater leptin (r = .28, p < .001) and lower ghrelin (r = .29, p = .003). In the model with ELS and covariates, psychiatric disorder remained significant (F=7.26, p = .008) and ELS was no longer significant (p = .87). Associations with severity and recent perceived stress were also examined. The relationship of ELS and leptin was no longer significant when accounting for BMI, suggesting potential avenues for intervention. Ghrelin findings persisted after correction for BMI, which may be secondary to physiological differences in the regulation of these hormones (leptin is produced by adipocytes, whereas ghrelin is produced primarily in the GI tract). Lastly, these findings suggest that psychiatric functioning may be a key component contributing to the relationship of lower total ghrelin and childhood adversity.
Sections du résumé
BACKGROUND
Childhood adversity is a major risk factor for cardiometabolic health problems. Stress-related changes in diet suggest a role for endocrine factors that influence dietary intake, such as leptin and ghrelin. These hormones influence metabolism and may contribute to the relationship of early adversity, mental, and cardiometabolic health. This study examined levels of leptin and ghrelin in a sample of young adults with and without early life stress (ELS).
METHODS
Young adults ages 18-40 (N = 200; 68.5% female) were recruited from the community. Participants with ELS (N = 118) had childhood maltreatment, and a subset, n = 92 (78.0%) also had parental loss, and n = 65 (55.1%) also had a current psychiatric disorder. Control participants (N = 82) had no maltreatment, parental loss, or psychiatric disorders. Standardized interviews and self-reports assessed demographics, adversity, medical/psychiatric history, and health behaviors. Exclusion criteria included medical conditions and current medications other than hormonal contraceptives. Body Mass Index (BMI) and other anthropometrics were measured, and fasting plasma was assayed for total ghrelin and leptin with the Bio-Plex Pro Human Diabetes Panel.
RESULTS
While ELS was significantly associated with greater leptin (r = .16, p = .025), a finding which held when adjusted for age and sex (F(3196)= 28.32, p = .011), this relationship was abolished when accounting for BMI (p = .44). Participants with ELS also had significantly lower total ghrelin (r = .21, p = .004), which held adjusting for age and sex (p = .002) and was attenuated (p = .045) when the model included BMI (F=46.82, p < .001). Current psychiatric disorder was also a significant predictor of greater leptin (r = .28, p < .001) and lower ghrelin (r = .29, p = .003). In the model with ELS and covariates, psychiatric disorder remained significant (F=7.26, p = .008) and ELS was no longer significant (p = .87). Associations with severity and recent perceived stress were also examined.
CONCLUSION
The relationship of ELS and leptin was no longer significant when accounting for BMI, suggesting potential avenues for intervention. Ghrelin findings persisted after correction for BMI, which may be secondary to physiological differences in the regulation of these hormones (leptin is produced by adipocytes, whereas ghrelin is produced primarily in the GI tract). Lastly, these findings suggest that psychiatric functioning may be a key component contributing to the relationship of lower total ghrelin and childhood adversity.
Identifiants
pubmed: 36577337
pii: S0306-4530(22)00348-1
doi: 10.1016/j.psyneuen.2022.106007
pmc: PMC9931677
mid: NIHMS1861053
pii:
doi:
Substances chimiques
Leptin
0
Ghrelin
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
106007Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA028408
Pays : United States
Organisme : NICHD NIH HHS
ID : T32 HD101392
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA011431
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH101107
Pays : United States
Organisme : NIMH NIH HHS
ID : R25 MH101076
Pays : United States
Organisme : NIAAA NIH HHS
ID : R37 AA011431
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no conflict of interest.
Références
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Neuroendocrinol. 2006 Nov;18(11):865-74
pubmed: 17026536
Diabetes. 2001 Aug;50(8):1714-9
pubmed: 11473029
Nutr Metab Cardiovasc Dis. 2015 May;25(5):479-88
pubmed: 25770759
J Trauma Stress. 1998 Jul;11(3):521-42
pubmed: 9690191
Psychiatry Investig. 2014 Apr;11(2):167-72
pubmed: 24843372
Clin Pharmacokinet. 2021 Apr;60(4):471-484
pubmed: 33155163
In Vivo. 2017 Nov-Dec;31(6):1047-1050
pubmed: 29102924
Obesity (Silver Spring). 2018 Jan;26(1):160-166
pubmed: 29090856
J Pediatr Endocrinol Metab. 2019 Oct 25;32(10):1043-1047
pubmed: 31472067
Psychiatry Res. 1986 May;18(1):65-87
pubmed: 3737788
Front Cell Neurosci. 2019 May 27;13:205
pubmed: 31191250
Psychoneuroendocrinology. 2017 Dec;86:73-77
pubmed: 28917185
JAMA. 2021 Feb 16;325(7):623-624
pubmed: 33492329
Mol Psychiatry. 2014 May;19(5):544-54
pubmed: 23689533
Biol Psychiatry. 2020 Oct 1;88(7):531-540
pubmed: 32912426
J Child Psychol Psychiatry. 1997 Mar;38(3):365-74
pubmed: 9232482
Physiol Res. 2016 Dec 22;65(Suppl 5):S557-S566
pubmed: 28006938
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Stress. 2015;18(3):328-42
pubmed: 26260665
Obes Res Clin Pract. 2016 Sep - Oct;10(5):580-588
pubmed: 26598448
Trends Endocrinol Metab. 2017 Dec;28(12):843-854
pubmed: 29097101
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E852-E862
pubmed: 32830551
J Child Psychol Psychiatry. 1994 Nov;35(8):1419-35
pubmed: 7868637
Mol Psychiatry. 2020 Feb;25(2):461-475
pubmed: 29728704
Horm Behav. 2010 Nov;58(5):808-19
pubmed: 20708008
J Clin Psychol. 1997 Jan;53(1):7-14
pubmed: 9120035
JAMA Psychiatry. 2019 Jun 1;76(6):584-593
pubmed: 30892562
Psychoneuroendocrinology. 2017 Mar;77:186-195
pubmed: 28088658
JAMA Netw Open. 2020 Aug 3;3(8):e2013946
pubmed: 32816030
Neuropsychobiology. 2012;66(3):185-92
pubmed: 22948519
Biol Sex Differ. 2022 Jun 15;13(1):29
pubmed: 35706066
Int J Mol Sci. 2017 Apr 19;18(4):
pubmed: 28422060
J Clin Endocrinol Metab. 2014 Jun;99(6):E1055-60
pubmed: 24650014
Child Abuse Negl. 2003 Feb;27(2):169-90
pubmed: 12615092
J Public Health (Oxf). 2015 Sep;37(3):445-54
pubmed: 25174044
Assessment. 2004 Dec;11(4):330-41
pubmed: 15486169
J Am Heart Assoc. 2020 May 5;9(9):e015326
pubmed: 32342717
Psychoneuroendocrinology. 2019 Jan;99:225-235
pubmed: 30286445
Mol Metab. 2015 Mar 21;4(6):437-60
pubmed: 26042199
Psychoneuroendocrinology. 2013 Mar;38(3):312-30
pubmed: 23313276
Obesity (Silver Spring). 2017 Apr;25(4):713-720
pubmed: 28349668
Metabolism. 2015 Jan;64(1):114-30
pubmed: 25092133
Mol Psychiatry. 2014 Dec;19(12):1284-94
pubmed: 24126924
Biol Psychiatry. 2017 Jun 15;81(12):1003-1013
pubmed: 28010876
Appetite. 2021 Jul 1;162:105180
pubmed: 33684530
Transl Psychiatry. 2014 Sep 23;4:e446
pubmed: 25247591
Eur Eat Disord Rev. 2021 Jul;29(4):588-599
pubmed: 33939220
Biol Psychiatry. 2019 Feb 1;85(3):268-278
pubmed: 30391001
Circulation. 2020 Nov 10;142(19):e321-e332
pubmed: 33028085
Transl Psychiatry. 2018 Apr 11;8(1):74
pubmed: 29643360